SecBot SecBot
SECBOTREPLAY Home › Report › PHGE

PHGE · BiomX Inc

BiomX Inc. · 424B5 filed Jul 27, 2026 at 17:00 ET

At the news

BEARISHIMPACT 7/10

424B5 filed Jul 27, 2026 at 17:00 ET

BiomX Inc. filed a prospectus supplement to its existing ATM offering agreement with H.C. Wainwright, updating the maximum aggregate offering price of common stock that may be sold under the shelf registration to $9.145 million. The company has already sold approximately $3.708 million under the program. With a market cap of only ~$2M and the stock trading at $0.1948, this represents massive potential dilution of over 450% of current market cap, signaling severe financial distress and a relentless need for cash.

  • BiomX filed a 424B5 prospectus supplement to sell up to $9,145,000 of common stock via an ATM agreement with H.C. Wainwright.
  • The company has already sold $3,708,127 under the ATM program prior to this supplement.
  • The stock closed at $0.1948 per share on the filing date, with a market cap of approximately $2 million.
  • The $9.145 million offering is over 4.5x the current market cap, implying extreme dilution.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access